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Production technologies providing high concentrations of membrane proteins in their native structure are 
essential in the vaccine field, as well as to support the drug discovery pipeline. In this work, we took advantage 
of insect cell expression and site specific gene integration based on flipase-mediated cassette exchange 
(FMCE) technology to develop cell platforms for efficient production of membrane proteins on the surface of 
enveloped virus-like particles (VLPs). The co-expression of membrane proteins with capsid proteins of 
enveloped viruses (such as HIV Gag) will enable their capturing in lipid rafts of the cellular plasma membrane 
and displaying on the surface of budding VLPs, thus providing a native conformation for downstream assays. 
Parental Sf9 and Hi5 insect cells were randomly tagged with a GFP-fused Gag protein and FACS enriched with 
cells tagged in genomic “hot-spots” supporting high expression. A linker including a Flp recognition target (FRT) 
site was used to allow posterior removal of the marker gene from the particle through cassette exchange. By 
confocal microscopy we could see that Gag localizes preferentially at the plasma membrane, whereas by 
electron microscopy we could detect correctly assembled Gag-VLPs in the culture supernatant of both cell 
hosts. Upon promoting Flp-mediated recombination in the tagging populations, cassette exchange was well-
succeeded (showing that the FRT site composing the linker fusing the two genes does not impact 
recombination), allowing to recover cells tagged in loci supporting FMCE. We are currently evaluating the 
capability of the Gag-VLPs as scaffolds to display GPCRs (e.g. beta-2 adrenergic receptor) and Influenza HA 
proteins. Overall, modular insect platforms are being constructed to be readily adaptable to produce a broad 
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